Skip to content
AI IntelligenceJun 20, 2026Secondary Market
Article

ADMA

ADMA Biologics was hit with a federal securities lawsuit over alleged revenue inflation. The lawsuit accuses the company of artificially inflating its financial results.

Data Cube AI EditorialSource: Yahoo Finance
01

Source Brief

ADMA Biologics was hit with a federal securities lawsuit over alleged revenue inflation. The lawsuit accuses the company of artificially inflating its financial results.